Stránka klinických studií Nct

Clinical Trial Results:
A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX-4 plus cetuximab versus UFOX plus cetuximab as first-line therapy in subjects with metastatic colorectal cancer

Summary
EudraCT number
2006-000685-36
Trial protocol
AT   FR   BE   GR   DE   IT  
Global completion date
15 May 2012

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
24 Jun 2016
First version publication date
24 Jun 2016
Other versions
Summary report(s)
2006-000685-36_Ct.gov results
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Předplatit